Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on June 3, 2025
Emerging Markets Report: Shedding Some Light
GlobeNewswire
·
June 3, 2025
An Emerging Markets Sponsored Commentary ORLANDO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- While there are no crystal balls in modern financial markets there are the words of those who know more, who share from the inside out the state of affairs inside a …
Gilat Signs a $40 Million Contract for Virtualized SkyEdge IV Platform
GlobeNewswire
·
June 3, 2025
PETAH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that it has received a $40 million contract for …
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswire
·
June 3, 2025
FREDERICK, Md., June 03, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the granting of inducement awards to …
Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent Advancements and Potential Recombinant Spider Silk Deliveries in 2025
GlobeNewswire
·
June 3, 2025
ANN ARBOR, Mich., June 03, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, issues a letter to shareholders. Dear Shareholders, We recently received inquiries …
Vanqua Bio to Present at Upcoming Scientific Conferences
GlobeNewswire
·
June 3, 2025
CHICAGO, June 03, 2025 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim Phase 1 data for its lead clinical program, VQ-101, at two upcoming scientific conferences – the GBA1 Meeting …
Supporting Regional Integration with Payment Services: UnionPay Attends the First ASEAN-GCC-China Economic Forum
GlobeNewswire
·
June 3, 2025
SHANGHAI, June 03, 2025 (GLOBE NEWSWIRE) -- From May 27 to 28, the ASEAN-GCC-China Economic Forum 2025 was held in Kuala Lumpur, Malaysia. Mr. Dong Junfeng, Chairman of China UnionPay and UnionPay International, was invited to attend the Forum, including …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 3, 2025
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted seven newly-hired employees restricted stock units (RSUs) …
VEON and Engro Corporation Complete Pioneering Infrastructure Partnership in Pakistan
GlobeNewswire
·
June 3, 2025
Islamabad and Dubai, June 3, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), announces that it has successfully closed the partnership for the pooling and management of telecommunications infrastructure assets in …
OXB Highlights the Launch of its Innovation and Technology Excellence Board
GlobeNewswire
·
June 3, 2025
Oxford, UK – 03 June 2025: OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, today highlights the launch of its Innovation and Technology Excellence Board (ITEB). The ITEB brings together leading experts in …
Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that …
Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor
GlobeNewswire
·
June 3, 2025
SUNRISE, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Transpire Bio Inc., a U.S.-based, integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an …
Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 3, 2025
SOUTH SAN FRANCISCO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
GlobeNewswire
·
June 3, 2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the appointment of Maha Radhakrishnan, M.D., to its Board of Directors. “We are pleased to have Dr. Radhakrishnan join the Board at this time of tremendous …
Greenbacker delivers first quarter results
GlobeNewswire
·
June 3, 2025
Company announces year-over-year increases in IPP revenue, power production, and generation capacity in its operating fleet, as well as construction milestones on largest solar project in New York Key Takeaways Against a backdrop of trade policy driven …
Next Hydrogen announces transition of its COO to a consulting arrangement
GlobeNewswire
·
June 3, 2025
MISSISSAUGA, Ontario, June 03, 2025 (GLOBE NEWSWIRE) -- Next Hydrogen Solutions Inc. (“Next Hydrogen“) (TSXV:NXH, OTC:NXHSF) announces that James Franchville, the company’s Chief Operating Officer, will be stepping down from his role and transitioning into …
I-Mab to Participate in the H.C. Wainwright “HCW@Home” Series
GlobeNewswire
·
June 3, 2025
ROCKVILLE, Md., June 03, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s …
Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
GlobeNewswire
·
June 3, 2025
WILMETTE, Ill., June 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today …
FactSet Announces CEO Succession Plan
GlobeNewswire
·
June 3, 2025
Sanoke Viswanathan Appointed Chief Executive Officer Effective Early September 2025 Phil Snow to Retire After Accomplished 30-Year Career with FactSet, Including 10 Years as CEO NORWALK, Conn., June 03, 2025 (GLOBE NEWSWIRE) -- FactSet (NYSE: FDS | NASDAQ: …
BioStem Technologies Provides Update on the Company’s Form 10 Submission and SEC Review Process
GlobeNewswire
·
June 3, 2025
POMPANO BEACH, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for …
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
GlobeNewswire
·
June 3, 2025
PRINCETON, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the publication of a post-hoc analysis of data from the ERT-experienced cohort of the PROPEL study of cipaglucosidase alfa-atga + miglustat (cipa+mig) in …